Skip to content
  • Home
  • Directory
  • Resources
    • Stem Cell Knowledge Hub
    • All articles
    • All Studies
    • Regenerative Health
    • Regenerative Aesthetics
    • Anti-Aging
    • Rheumatoid Arthritis
    • Multiple Sclerosis (MS)​
    • Crohn’s Disease​​
    • LUPUS
    • Parkinson’s Disease​
    • Long Covid
    • Epstein-Barr
    • Ulcerative Colitis
  • Blog
  • About Us
  • Contact
  • Home
  • Directory
  • Resources
    • Stem Cell Knowledge Hub
    • All articles
    • All Studies
    • Regenerative Health
    • Regenerative Aesthetics
    • Anti-Aging
    • Rheumatoid Arthritis
    • Multiple Sclerosis (MS)​
    • Crohn’s Disease​​
    • LUPUS
    • Parkinson’s Disease​
    • Long Covid
    • Epstein-Barr
    • Ulcerative Colitis
  • Blog
  • About Us
  • Contact

Day: January 14, 2025

Can We Really Reverse Aging? Human Trials are Testing the Possibility

Human trials are exploring a future where aging is not just slowed but possibly reversed. The treatments focus on senolytic drugs, targeting aging cells — could we soon see a future where time is no longer our enemy?

Stemcyte’s HPC Cord Blood Treatment Provides Relief for Long Covid Fatigue

Stemcyte’s new trial results offer a potential solution for those still struggling with the overwhelming fatigue of Long Covid. A promising treatment using HPC cord blood has given many patients relief.

First Patient Receives FDA-Approved Tremfya for Ulcerative Colitis Treatment at UChicago

Tremfya (guselkumab) has been administered to a patient with ulcerative colitis for the first time. This FDA-approved treatment is offering new possibilities for those battling this challenging condition.

The RHA.org Your Trusted Guide to Regenerative Health

Facebook-f Linkedin
Quick Links
  • home
  • Directory
  • Stem Cell Knowledge Hub
  • Blog
  • About The RHA
  • Privacy Policy
  • Contact Us
  • home
  • Directory
  • Stem Cell Knowledge Hub
  • Blog
  • About The RHA
  • Privacy Policy
  • Contact Us
Get In Touch

[email protected]

© 2025 All Rights Reserved.